Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies)

Vox Sanguinis

Volumn 73, Issue 3, 1997, Pages 149-154

  Morand Joiibert, Laurence ^a   Vittecoq, Daniel ^b   Roudot Thoravar, Françoise ^c   Mariotti, Martine ^d   Lefrère, François ^d   Heshmati, Farad ^e   Audat, Françoise ^f   Lambin, Patrick ^a   Barré Sinoiissi, Françoise ^a   Lefrère, Jean Jacques ^b   Lefrere J J ^d  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIROLOGY; VIRUS TITRATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; HIV ANTIBODIES; HUMANS; IMMUNIZATION, PASSIVE; INTERLEUKIN-1; INTERLEUKIN-6; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 0030708931     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7330149.x     Document Type: Article

References (13)

1. Jackson CG, Pcrkins JT, Rubenis M, Paul DA, Knigge M, Despotes JC, Spencer P: Passive immunoneutralisation of human immunodeficiency vims in patients with advanced AIDS. Lancet 1988;ii:647-652.
2. Karpas A, Hewlett IK, Hill F, Gray J, Byron N, Gilgen D, Bally V, Gates JK, Gazzard B, Epstein JE: Polymerase chain reaction for human immunodeficiency virus I neutralization by passive immunization in patients with AIDS and AIDS-rclated complex. Proc NatI Acad Sci USA 1990;87:7613-76I7.
3. Vittecoq D, Mattlinger B, Barre-Sinoussi F, Couroucé AM, Rouzioux C, Doinel C, Salmon C, Viard JP, Bach JF, Rouger P, Lefrère JJ: Passive immunotherapy in AIDS: A randomized trial of serial human immunodeficiency viruspositive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. J Infect Dis 1992;64:364-368.
4. Jacobson JM, Colman N, Ostrow NA, Simson RW, Tomesch D, Marlin L, Rao M, Mills JL, Clemens J, Prince AM: Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. J Infect Dis 1993; 168:298-305.
5. Vittecoq D, Chevert S, Morand-Joubcrt L, Hcshmati F, Audat F, Bary M, DusautoirT, Bismuth A, Viard JP, Barré-Sinoussi F, Bach JF, Lefrère JJ: Passive immunotherapy in AIDS: A double blind randomized study based on transfusions of plasma rich in anti-HIV-1 antibodies versus transfusions of seronegative plasma. Proc Natl Acad Sci USA 1995;92:1195-1199.
6. Morand-Joubert L, Costagliola D, Bludau H, Petit JC, Lefrère JJ: Predicting progression of HIV disease: usefulness of acid dissociated p24 antigen.J AIDS 1994;7:676-680.
7. Lefrère JJ, Roudot-Thoraval F, Vittecoq D, et al: Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma rich in HIV antibodies (passive immunotherapy). Transfusion 1996;36:734-738.
8. Kiev-its T, VanGemcn B, VanStrijp D, Schukkink R, Dircks M, Adriaanse H, Malek L, Sooknanan R, Lens P: NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 1991;35:273-286.
9. VanGemen B, VanBeuningen R, Nabbe A, VanStrijp D, Jurrians S, Kievits T: A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods 1994;49:I57-168.
10. Ho DD, Mougdil T, Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989; 321:1621-1625.
11. Daar ES, Moudgil T, Meyer RD, Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency HIV infection. N EnglJ Med 1991 ;324:961 -964.
12. Levy J, Youvan T, Lee ML and the Passive Hypcrimmune Therapy Study Group: Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: Results of a 12-month multicenter double-blind controlled trial. Blood 1994;84:2130-2135.
13. Walker CM, Erickson AL, Hsueh FC, Levy JA: Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytoto.xic mechanism. J Virol 1991;65:592I-5927.